WHO ICTRP trial
Faster insulin aspart (FiASP) vs. apart using an advanced closed-loop system…
ACTRN12619001340123 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12619001340123 |
|---|---|
| Public title | Faster insulin aspart (FiASP) vs. apart using an advanced closed-loop system: Extension study evaluating meal-time glucose control |
| Scientific title | Systems performance and glucose control with the Medtronic advanced hybrid closed loop system (A-HCL) using insulin aspart vs faster acting insulin aspart (FiASP): Extension study evaluating meal-time glucose control |
| Primary sponsor | Medtronic Diabetes |
| Secondary sponsors | Novo Nordisk Pharmaceuticals Pty Ltd |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | Australia |
| Conditions | type 1 diabetes; type 1 diabetes;Metabolic and Endocrine - Diabetes |
| Interventions | An extension to the study ACTRN12619000469112. This is a crossover study comparing glucose control using an advanced hybrid closed-loop (A-HCL) system delivering faster acting insulin aspart (FiASP) vs. insulin aspart in adults with type 1… |
| Registration date | Sep 30, 2019 |
| Target size | 12 |
| Secondary IDs | Nil |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: